| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_421edffacfeb6c6df7e383136565f3a1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
2016-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef0aadcd22e4d834148c55ba9dfd20e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa2cc9bf1235fc5a6091e89cb891aa61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d99e9e98e07ca04661c4fce58b1bdd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b704d463c6e9121102a30e655f653d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51112c40c7bfca3d7b095a21ed8e68c6 |
| publicationDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2016397046-B2 |
| titleOfInvention |
Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
| abstract |
This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of inflammatory conditions. |
| priorityDate |
2016-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |